{"schema":"hottub-news/story/v1","story":"st_nym7t7ml65i243e4vsfq","title":"Merck and Daiichi Withdraw Small Cell Lung Cancer Drug Bid After FDA Signals Phase 2 Data Fell Short","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/merck-and-daiichi-withdraw-small-cell-lung-cancer-drug-bid-after-fda-nym7t7ml65","count":1,"items":[{"id":"n_nym7t7ml65i243e4vsfq","seq":823389,"kind":"article","title":"Merck and Daiichi Withdraw Small Cell Lung Cancer Drug Bid After FDA Signals Phase 2 Data Fell Short","url":"https://www.medicaldaily.com/merck-daiichi-ifinatamab-deruxtecan-sclc-application-withdrawn-479280","summary":"Merck and Daiichi pulled their bid for accelerated approval of I-DXd in small-cell lung cancer after FDA feedback. What patients should ask now.","published":"2026-09-30T04:17:45Z","seen":"2026-09-30T04:49:13Z","lang":"en","source":{"id":"kite-medicaldaily-com-05fda3","name":"medicaldaily.com","domain":"medicaldaily.com","outlet":{"wikidata":"Q69052919","name":"Medical Daily","type":"website","country":"US","designations":["website"]}},"via":"kite-medicaldaily-com-05fda3","topics":["medicine"],"entities":[{"id":"Q96472579","name":"Merck","type":"org"},{"id":"Q49107945","name":"Best Denki (Taiwan)","type":"org"}],"mentions":2,"story":"st_nym7t7ml65i243e4vsfq","category":"health","category_p":0.49000000953674316,"category2":"economy-business","sentiment":"negative","tone":-0.5,"political":0.2199999988079071}]}